Sandeep Sehdev

1.0k citations

35 papers · 451 indexed · h-index 13

Impact in

Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections

Papers in ⓘ

Cancer Research 14
- Breast Cancer Treatment Studies 13
Oncology 25
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 7
- Global Cancer Incidence and Screening 4

Co-authors: Sunil Verma (5 shared papers)John Crown (4 shared papers)Tadeusz Pieńkowski (4 shared papers)W. Eiermann (4 shared papers)Guido Sauter (3 shared papers)Semiglazov Vf (3 shared papers)Mansoor N. Saleh (3 shared papers)Louise Provencher (3 shared papers)
Journals: Annals of Oncology (2 papers)Journal of Clinical Oncology (2 papers)Cancer Research (2 papers)Current Oncology (16 papers)Journal of Thoracic Oncology (1 paper)
Partner nations: Canada United States Spain

In The Last Decade

Sandeep Sehdev

34 papers receiving 440 citations

Peers

Countries citing papers authored by Sandeep Sehdev

Since Specialization

Citations

This map shows the geographic impact of Sandeep Sehdev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandeep Sehdev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandeep Sehdev more than expected).

Fields of papers citing papers by Sandeep Sehdev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandeep Sehdev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandeep Sehdev. The network helps show where Sandeep Sehdev may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandeep Sehdev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandeep Sehdev Line = papers co-authored together Sandeep Sehdev links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2–Normal, Node-Positive Breast Cancer: BCIRG-005 Trial Journal of Clinical Oncology ·W. Eiermann, Tadeusz Pieńkowski, John Crown, Saeed Sadeghi, Miguel Martín, Arlene Chan, Mansoor N. Saleh, Sandeep Sehdev, Louise Provencher, Semiglazov Vf, Michael F. Press, Guido Sauter, Mark A. Lindsay, A. Riva, Marc Buyse, Philippe Drevot, Henry Taupin, John R. Mackey	2011	108
2	Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial Annals of Oncology ·John R. Mackey, Tadeusz Pieńkowski, John Crown, Saeed Sadeghi, Miguel Martín, Arlene Chan, Mansoor N. Saleh, Sandeep Sehdev, Louise Provencher, Semiglazov Vf, Michael F. Press, Guido Sauter, Mary-Ann Lindsay, Vincent Houé, Marc Buyse, Philippe Drevot, Simon Hitier, Samira Bensfia, W. Eiermann	2016	48
3	Challenges to Implementation of an Epidermal Growth Factor Receptor Testing Strategy for Non–Small-Cell Lung Cancer in a Publicly Funded Health Care System Journal of Thoracic Oncology ·Peter Ellis, Sunil Verma, Sandeep Sehdev, Jawaid Younus, Natasha B. Leighl	2013	32
4	Safety of Adjuvant Endocrine Therapies in Hormone Receptor–Positive Early Breast Cancertissues Current Oncology ·Sandeep Sehdev, G. Martin, Lucas Sidéris, Wwt Lam, Stéphanie Brisson	2009	24
5	Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting Current Oncology ·Sunil Verma, Yolanda Madarnas, Sandeep Sehdev, G. Martin, Jana Bajcar	2011	23
6	BCIRG 005 main efficacy analysis: a phase III randomized trial comparing docetaxel in combination with doxorubicin and cyclophosphamide (TAC) versus doxorubicin and cyclophosphamide followed by docetaxel (AC→T) in women with Her-2/neu negative axillary lymph node positive early breast cancer. Cancer Research ·W. Eiermann, Tadeusz Pieńkowski, John Crown, Linnea Chap, Marek Pawlicki, M Martin, Mansoor N. Saleh, Sandeep Sehdev, Louise Provencher, G. von Minckwitz, Semiglazov Vf, Dennis J. Slamon, Isabelle Tabah-Fisch, M. Buyse, Agostino Riva, Henry Taupin, Guido Sauter, J. Mackey, (unknown)	2009	23
7	A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting The Breast ·Mark Clemons, George Dranitsaris, Marta Sienkiewicz, Sandeep Sehdev, Terry L. Ng, Andrew Robinson, Mihaela Mates, Tina Hsu, Sharon F. McGee, Orit Freedman, Vikaash Kumar, Dean Fergusson, Brian Hutton, Lisa Vandermeer, John Hilton	2020	21
8	HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review Current Oncology ·Katarzyna J. Jerzak, Nathaniel Bouganim, Christine Brezden‐Masley, Scott Edwards, Karen A. Gelmon, Jan‐Willem Henning, John Hilton, Sandeep Sehdev	2023	21
9	Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer: Results from the BCIRG 006 Study The Oncologist ·Heather‐Jane Au, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, John Crown, Miguel Martín, Marek Pawlicki, Arlene Chan, John R. Mackey, John A. Glaspy, Tamás Pintér, Mei-Ching Liu, Tommy� Fornander, Sandeep Sehdev, Jean-Marc Ferrero, Valerie Bée, Maria Santana, Dave P. Miller, Deepa Lalla, Dennis J. Slamon	2013	19
10	Models of Care for Early-Stage Breast Cancer in Canada Current Oncology ·Yolanda Madarnas, Aska Joy, Sunil Verma, Sandeep Sehdev, Wwt Lam, Lucas Sidéris	2011	17
11	Sunitinib toxicity management – a practical approach Canadian Urological Association Journal ·Sandeep Sehdev	2016	16
12	Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic Current Oncology ·Tabitha Tse, Sandeep Sehdev, Jean M. Seely, Denis Gravel, Mark Clemons, Erin Cordeiro, Angel Arnaout	2021	14
13	Cancer Therapy Disparity: Unequal Access to Breast Cancer Therapeutics and Drug Funding in Canada Current Oncology ·Sunil Verma, Sandeep Sehdev, A. A. Joy	2007	12
14	Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel Dermatology and Therapy ·Kim Papp, Barbara Melosky, Sandeep Sehdev, Sébastien J. Hotte, Jennifer Beecker, Mark G. Kirchhof, Irina Turchin, Jan Dutz, Melinda Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles Lynde, Vimal H. Prajapati, Ronald Vender	2023	10
15	Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm Therapeutic Advances in Medical Oncology ·Charlie Yang, Christine Brezden‐Masley, Anil A. Joy, Sandeep Sehdev, Shanu Modi, Christine Simmons, Jan‐Willem Henning	2023	8
16	Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial Journal of Evaluation in Clinical Practice ·Susan J. Robertson, Mohammed Ibrahim, Carol Stober, John Hilton, Zuzana Kos, Sasha Mazzarello, Tim Ramsay, Dean Fergusson, Lisa Vandermeer, Ranjeeta Mallick, Angel Arnaout, Susan Dent, Roanne Segal, Sandeep Sehdev, S. Gertler, Brian Hutton, Mark Clemons	2019	7
17	Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey Supportive Care in Cancer ·Mashari Alzahrani, Mark Clemons, Marta Sienkiewicz, Noa Shani Shrem, Sharon F. McGee, Lisa Vandermeer, Sandeep Sehdev, Marie-France Savard, Arif Awan, Christina Canil, Brian Hutton, Gregory R. Pond, Deanna Saunders, Terry L. Ng	2021	6
18	Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada: A Call to Action Current Oncology ·Sandeep Sehdev, Joanna Gotfrit, Martine Elias, Barry D. Stein	2024	6
19	New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices Current Oncology ·David J. Stewart, John‐Peter Bradford, Sandeep Sehdev, Tim Ramsay, Vishal Navani, Nigel S. B. Rawson, Di Jiang, Joanna Gotfrit, Paul Wheatley‐Price, Geoffrey Liu, Alan Kaplan, Silvana Spadafora, Shaun G. Goodman, Rebecca C. Auer, Gerald Batist	2024	5
20	Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement Current Oncology ·Sandeep Sehdev, Nigel S. B. Rawson, Olexiy I. Aseyev, Catriona Buick, Marcus O. Butler, Scott Edwards, Sharlene Gill, Joanna Gotfrit, Cyrus C. Hsia, Rosalyn A. Juergens, Mita Manna, Joy McCarthy, Som D. Mukherjee, Stephanie Snow, Silvana Spadafora, David J. Stewart, Jason Wentzell, Ralph Wong, Paweł Zalewski	2024	4

About Sandeep Sehdev

Sandeep Sehdev is a scholar working on Cancer Research, Oncology, Family Practice, Pulmonary and Respiratory Medicine and Economics and Econometrics, having authored 35 papers that have together received 451 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), HER2/EGFR in Cancer Research (7 papers), Economic and Financial Impacts of Cancer (6 papers), Advanced Breast Cancer Therapies (6 papers), Pharmaceutical Economics and Policy (5 papers) and Global Cancer Incidence and Screening (4 papers). The work is most often cited by research in Cancer Research (201 citations), Oncology (272 citations), Family Practice (19 citations), Pulmonary and Respiratory Medicine (122 citations) and Dermatology (15 citations). Sandeep Sehdev has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include Sunil Verma, John Crown, Tadeusz Pieńkowski, W. Eiermann, Guido Sauter, Semiglazov Vf, Mansoor N. Saleh, Louise Provencher, Marc Buyse and Miguel Martín. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, Current Oncology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact